Efficacy and safety of liraglutide versus sitagliptin both in combination with metformin in patients with type 2 diabetes A systematic review and meta-analysis

被引:26
|
作者
Li, Mingxing [1 ]
Yang, Yi [1 ]
Jiang, Deqi [2 ]
Ying, Miaofa [1 ]
Wang, Yong [3 ]
Zhao, Rui [1 ]
机构
[1] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pharm, 3 Qingchun East Rd, Hangzhou 310016, Zhejiang, Peoples R China
[2] Yulin Normal Univ, Dept Biopharmaceut, Yulin, Peoples R China
[3] Southern Med Univ, Zhu Jiang Hosp, Dept Pharm, Guangzhou, Guangdong, Peoples R China
关键词
diabetes mellitus; liraglutide; meta-analysis; metformin; randomized controlled trials; sitagliptin;
D O I
10.1097/MD.0000000000008161
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aim of this systematic review was to evaluate the efficacy and safety of liraglutide versus sitagliptin both in combination with metformin in patients with type 2 diabetes and provide reference basis for rational use of clinical drugs. Methods: Several databases were searched, including Web of science, PubMed, Cochrane library, CNKI, and Wanfang database. Only randomized controlled trials (RCTs) of liraglutide versus sitagliptin both in combination with metformin up to 31 August 2016 were included. Data were extracted independently by 2 reviewers, and a fixed or random effects model were used to analyze outcomes that were expressed as odds ratio (OR) or mean difference (MD) and 95% confidence intervals (95% CIs) for different situations. Results: Five RCTs involving 1440 participants were included. Compared with sitagliptin combination with metformin group, participants' treatment with 1.2mg and 1.8mg liraglutide with metformin could significantly lower the level of glycosylated hemoglobin (HbA1c) (P<.00001, MD=-0.35, 95% CI -0.51 to -0.20). Moreover, patients with 1.8mg liraglutide group had significant body weight loss (P<.00001, MD= -1.12, 95% CI -1.54 to -0.70). However, there were no obvious differences in cutting down the systolic blood pressure and diastolic blood pressure between liraglutide-metformin and sitagliptin-metformin groups. The incidence of gastrointestinal problems was significantly higher than sitagliptin with metformin groups. Conclusion: The results of this meta-analysis indicated that Liraglutide added on to metformin therapy could significantly lower the level of HbA1c and increase body weight loss. Meanwhile, the adverse reactions such as gastrointestinal problems were common in the liraglutide treatment group. Thus, this will provide an important reference for the treatment of patients with type 2 diabetes.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Efficacy and safety of bexagliflozin in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
    Pasqualotto, Eric
    Watanabe, Janine Midori Figueiredo
    Gewehr, Douglas Mesadri
    Maintinguer, Raphaela da Silva
    van de Sande-Lee, Simone
    de Araujo, Gustavo Neves
    Leal, Fidel Silveira
    Pinheiro, Carlos Eduardo Andrade
    DIABETES OBESITY & METABOLISM, 2023, 25 (07): : 1794 - 1802
  • [22] Efficacy and safety of luseogliflozin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Galigutta, Reddikumar Reddy
    Hasik, P. N.
    Thomas, Christy
    Undela, Krishna
    ENDOCRINE, 2024, : 620 - 630
  • [23] Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta-analysis
    Liakos, A.
    Karagiannis, T.
    Athanasiadou, E.
    Sarigianni, M.
    Mainou, M.
    Papatheodorou, K.
    Bekiari, E.
    Tsapas, A.
    DIABETES OBESITY & METABOLISM, 2014, 16 (10): : 984 - 993
  • [24] Efficacy and Safety of Ertugliflozin in Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Liu, Li
    Shi, Fang-Hong
    Xu, Hua
    Wu, Yue
    Gu, Zhi-Chun
    Lin, Hou-Wen
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [25] Efficacy and safety of fixed-ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta-analysis of randomised controlled trials
    Wang, Rui
    Luo, Shuoming
    Xiao, Zilin
    Zhou, Zhiguang
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2024, 40 (03)
  • [26] Liraglutide combined with metformin treatment for obese people with type 2 diabetes mellitus: a systematic review and meta-analysis
    Yang Long
    Yuxi Zhang
    Irish Journal of Medical Science (1971 -), 2023, 192 : 2809 - 2814
  • [27] Liraglutide combined with metformin treatment for obese people with type 2 diabetes mellitus: a systematic review and meta-analysis
    Long, Yang
    Zhang, Yuxi
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (06) : 2809 - 2814
  • [28] Comparative effects of sitagliptin and metformin in patients with type 2 diabetes mellitus: a meta-analysis
    Du, Qiang
    Wu, Bo
    Wang, Yan-Jun
    Yang, Sheng
    Zhao, Yue-Yang
    Liang, Yuan-yuan
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (11) : 1487 - 1494
  • [29] Efficacy and safety of metformin in adult patients with type 1 diabetes: a meta-analysis
    Tan, Ying
    Lin, Qiongyan
    Wang, Chaofan
    Xu, Wen
    Wei, Xueying
    Zhang, Yao
    Yang, Xubin
    Yan, Jinhua
    Yao, Bin
    Weng, Jianping
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [30] Efficacy and Safety of Metformin for Patients with Type 1 Diabetes Mellitus: A Meta-Analysis
    Liu, Cong
    Wu, Dan
    Zheng, Xuan
    Li, Ping
    Li, Ling
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (02) : 142 - 148